Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH).

Lewis J, McCarten K, Kurch L, Flerlage JE, Kaste SC, Kluge R, Stoevesandt D, Voss SD, Kelly KM, Mauz-Körholz C, Drachtman RA, Metzger ML.

Pediatr Blood Cancer. 2020 Apr;67(4):e28142. doi: 10.1002/pbc.28142. Epub 2019 Dec 22. Review.

PMID:
31867838
2.

Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312).

Cole KA, Pal S, Kudgus RA, Ijaz H, Liu X, Minard CG, Pawel BR, Maris JM, Haas-Kogan DA, Voss SD, Berg SL, Reid JM, Fox E, Weigel BJ.

Clin Cancer Res. 2020 Mar 15;26(6):1213-1219. doi: 10.1158/1078-0432.CCR-19-3470. Epub 2019 Dec 19.

PMID:
31857431
3.

Surveillance imaging in pediatric lymphoma.

Voss SD, Cairo MS.

Pediatr Radiol. 2019 Oct;49(11):1565-1573. doi: 10.1007/s00247-019-04511-4. Epub 2019 Oct 16. Review.

PMID:
31620855
4.

Functional and anatomical imaging in pediatric oncology: which is best for which tumors.

Voss SD.

Pediatr Radiol. 2019 Oct;49(11):1534-1544. doi: 10.1007/s00247-019-04489-z. Epub 2019 Oct 16. Review.

PMID:
31620853
5.

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial.

Park JR, Kreissman SG, London WB, Naranjo A, Cohn SL, Hogarty MD, Tenney SC, Haas-Kogan D, Shaw PJ, Kraveka JM, Roberts SS, Geiger JD, Doski JJ, Voss SD, Maris JM, Grupp SA, Diller L.

JAMA. 2019 Aug 27;322(8):746-755. doi: 10.1001/jama.2019.11642.

6.

Multicenter pre-operative assessment of pediatric ovarian malignancy.

Madenci AL, Vandewalle RJ, Dieffenbach BV, Laufer MR, Boyd TK, Voss SD, Frazier AL, Billmire DF, Rescorla FJ, Weil BR, Weldon CB.

J Pediatr Surg. 2019 Sep;54(9):1921-1925. doi: 10.1016/j.jpedsurg.2019.02.019. Epub 2019 Feb 25.

PMID:
30867096
7.

A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921).

Mossé YP, Fox E, Teachey DT, Reid JM, Safgren SL, Carol H, Lock RB, Houghton PJ, Smith MA, Hall D, Barkauskas DA, Krailo M, Voss SD, Berg SL, Blaney SM, Weigel BJ.

Clin Cancer Res. 2019 Jun 1;25(11):3229-3238. doi: 10.1158/1078-0432.CCR-18-2675. Epub 2019 Feb 18.

PMID:
30777875
8.

Chemical cross-linking of a variety of green fluorescent proteins as Förster resonance energy transfer donors for Yukon orange fluorescent protein: A project-based undergraduate laboratory experience.

Marchioretto MK, Horton JT, Berstler CA, Humphries JB, Koloditch IJ, Voss SD, de La Harpe K, Hicks BW, Jefferies LR.

Biochem Mol Biol Educ. 2018 Sep;46(5):516-522. doi: 10.1002/bmb.21158. Epub 2018 Oct 3.

PMID:
30281890
9.

Staging and following common pediatric malignancies: MRI versus CT versus functional imaging.

Voss SD.

Pediatr Radiol. 2018 Aug;48(9):1324-1336. doi: 10.1007/s00247-018-4162-4. Epub 2018 Aug 4. Review.

PMID:
30078040
10.

Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.

Keller FG, Castellino SM, Chen L, Pei Q, Voss SD, McCarten KM, Senn SL, Buxton AB, Bush R, Constine LS, Schwartz CL.

Cancer. 2018 Aug 1;124(15):3210-3219. doi: 10.1002/cncr.31519. Epub 2018 May 8.

11.

A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group.

Chuk MK, Widemann BC, Minard CG, Liu X, Kim A, Bernhardt MB, Kudgus RA, Reid JM, Voss SD, Blaney S, Fox E, Weigel BJ.

Pediatr Blood Cancer. 2018 Aug;65(8):e27077. doi: 10.1002/pbc.27077. Epub 2018 Apr 25.

12.

Correction to: Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations.

Callahan MJ, MacDougall RD, Bixby SD, Voss SD, Robertson RL, Cravero JP.

Pediatr Radiol. 2018 Mar;48(3):454. doi: 10.1007/s00247-017-4057-9.

PMID:
29368012
13.

Imaging Optimization in Children.

Robertson RL, Silk S, Ecklund K, Bixby SD, Voss SD, Robson CD.

J Am Coll Radiol. 2018 Mar;15(3 Pt A):440-443. doi: 10.1016/j.jacr.2017.10.017. Epub 2017 Dec 29. No abstract available.

PMID:
29290593
14.

Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations.

Callahan MJ, MacDougall RD, Bixby SD, Voss SD, Robertson RL, Cravero JP.

Pediatr Radiol. 2018 Jan;48(1):21-30. doi: 10.1007/s00247-017-4023-6. Epub 2017 Nov 27. Review. Erratum in: Pediatr Radiol. 2018 Jan 25;:.

PMID:
29181580
15.

How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting.

Colleran GC, Kwatra N, Oberg L, Grant FD, Drubach L, Callahan MJ, MacDougall RD, Fahey FH, Voss SD.

Cancer Imaging. 2017 Nov 7;17(1):28. doi: 10.1186/s40644-017-0130-8. Review.

16.

Role of imaging in the diagnosis of parotid infantile hemangiomas.

Weber FC, Greene AK, Adams DM, Liang MG, Alomari MH, Voss SD, Chaudry G.

Int J Pediatr Otorhinolaryngol. 2017 Nov;102:61-66. doi: 10.1016/j.ijporl.2017.08.035. Epub 2017 Sep 4.

PMID:
29106877
17.

Liposuction for Swelling in Patients with Lymphedema.

Greene AK, Voss SD, Maclellan RA.

N Engl J Med. 2017 Nov 2;377(18):1788-1789. doi: 10.1056/NEJMc1709275. No abstract available.

PMID:
29091562
18.

Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study.

O'Neill AF, Voss SD, Jagannathan JP, Kamihara J, Nibecker C, Itriago-Araujo E, Masciari S, Parker E, Barreto M, London WB, Garber JE, Diller L.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26822. Epub 2017 Oct 27.

PMID:
29077256
19.

Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

Mossé YP, Voss SD, Lim MS, Rolland D, Minard CG, Fox E, Adamson P, Wilner K, Blaney SM, Weigel BJ.

J Clin Oncol. 2017 Oct 1;35(28):3215-3221. doi: 10.1200/JCO.2017.73.4830. Epub 2017 Aug 8.

20.

Operational and Dosimetric Aspects of Pediatric PET/CT.

Fahey FH, Goodkind A, MacDougall RD, Oberg L, Ziniel SI, Cappock R, Callahan MJ, Kwatra N, Treves ST, Voss SD.

J Nucl Med. 2017 Sep;58(9):1360-1366. doi: 10.2967/jnumed.116.182899. Epub 2017 Jul 7. Review.

21.

Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood.

Rednam SP, Erez A, Druker H, Janeway KA, Kamihara J, Kohlmann WK, Nathanson KL, States LJ, Tomlinson GE, Villani A, Voss SD, Schiffman JD, Wasserman JD.

Clin Cancer Res. 2017 Jun 15;23(12):e68-e75. doi: 10.1158/1078-0432.CCR-17-0547. Review.

22.

Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders.

Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Druker H, Scott HS, Tabori U.

Clin Cancer Res. 2017 Jun 15;23(12):e54-e61. doi: 10.1158/1078-0432.CCR-17-0590. Review.

23.

Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1.

Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Schneider KW, Scott HS, Plon SE, Tabori U.

Clin Cancer Res. 2017 Jun 15;23(12):e46-e53. doi: 10.1158/1078-0432.CCR-17-0589. Review.

24.

Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI.

Greer MC, Voss SD, States LJ.

Clin Cancer Res. 2017 Jun 1;23(11):e6-e13. doi: 10.1158/1078-0432.CCR-17-0515. Review.

25.

Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma.

Gauguet JM, Pace-Emerson T, Grant FD, Shusterman S, DuBois SG, Frazier AL, Voss SD.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26601. Epub 2017 Apr 27.

PMID:
28449267
26.

Hepatocellular Carcinoma in Fanconi-Bickel Syndrome.

Pogoriler J, O'Neill AF, Voss SD, Shamberger RC, Perez-Atayde AR.

Pediatr Dev Pathol. 2018 Jan-Feb;21(1):84-90. doi: 10.1177/1093526617693540. Epub 2017 Apr 6.

PMID:
28382841
27.

Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.

Flerlage JE, Kelly KM, Beishuizen A, Cho S, De Alarcon PA, Dieckmann U, Drachtman RA, Hoppe BS, Howard SC, Kaste SC, Kluge R, Kurch L, Landman-Parker J, Lewis J, Link MP, McCarten K, Punnett A, Stoevesandt D, Voss SD, Wallace WH, Mauz-Körholz C, Metzger ML.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26421. Epub 2017 Jan 18.

PMID:
28097818
28.

Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group.

Schwartz CL, Chen L, McCarten K, Wolden S, Constine LS, Hutchison RE, de Alarcon PA, Keller FG, Kelly KM, Trippet TA, Voss SD, Friedman DL.

Pediatr Blood Cancer. 2017 Apr;64(4). doi: 10.1002/pbc.26278. Epub 2016 Oct 27.

29.

Features and Outcome of Autonomous Thyroid Nodules in Children: 31 Consecutive Patients Seen at a Single Center.

Ly S, Frates MC, Benson CB, Peters HE, Grant FD, Drubach LA, Voss SD, Feldman HA, Smith JR, Barletta J, Hollowell M, Cibas ES, Moore FD Jr, Modi B, Shamberger RC, Huang SA.

J Clin Endocrinol Metab. 2016 Oct;101(10):3856-3862. Epub 2016 Aug 8.

30.

Preoperative risk stratification of children with ovarian tumors.

Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Zurakowski D, Frazier AL, Weldon CB.

J Pediatr Surg. 2016 Sep;51(9):1507-12. doi: 10.1016/j.jpedsurg.2016.05.004. Epub 2016 May 31.

PMID:
27289417
31.

Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management.

O'Neill AF, Adil EA, Irace AL, Neff L, Davis IJ, Perez-Atayde AR, Voss SD, Weinberg O, Rahbar R.

Int J Pediatr Otorhinolaryngol. 2016 Jul;86:218-23. doi: 10.1016/j.ijporl.2016.04.035. Epub 2016 Apr 30. Review.

PMID:
27260610
32.

Poor adherence to staging guidelines for children with malignant ovarian tumors.

Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Frazier AL, Weldon CB.

J Pediatr Surg. 2016 Sep;51(9):1513-7. doi: 10.1016/j.jpedsurg.2016.03.015. Epub 2016 Apr 11.

PMID:
27125730
33.

The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution.

Dearling JL, Paterson BM, Akurathi V, Betanzos-Lara S, Treves ST, Voss SD, White JM, Huston JS, Smith SV, Donnelly PS, Packard AB.

Bioconjug Chem. 2015 Apr 15;26(4):707-17. doi: 10.1021/acs.bioconjchem.5b00049. Epub 2015 Mar 12.

PMID:
25719414
34.

Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium.

Voss SD, Glade-Bender J, Spunt SL, DuBois SG, Widemann BC, Park JR, Leary SE, Nelson MD, Adamson PC, Blaney SM, Weigel B.

Pediatr Blood Cancer. 2015 Jan;62(1):45-51. doi: 10.1002/pbc.25229. Epub 2014 Sep 24.

35.

Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group.

Weigel B, Malempati S, Reid JM, Voss SD, Cho SY, Chen HX, Krailo M, Villaluna D, Adamson PC, Blaney SM.

Pediatr Blood Cancer. 2014 Mar;61(3):452-6. doi: 10.1002/pbc.24605. Epub 2013 Aug 17.

36.

Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report.

Glade Bender JL, Lee A, Reid JM, Baruchel S, Roberts T, Voss SD, Wu B, Ahern CH, Ingle AM, Harris P, Weigel BJ, Blaney SM.

J Clin Oncol. 2013 Aug 20;31(24):3034-43. doi: 10.1200/JCO.2012.47.0914. Epub 2013 Jul 15.

37.

The radiographic appearance of split Blake drains: what you see is not necessarily what you get.

Gauguet JM, Prabhu SP, Pigula F, Voss SD.

Pediatr Radiol. 2013 Dec;43(12):1573-6. doi: 10.1007/s00247-013-2749-3. Epub 2013 Jul 11.

PMID:
23843132
38.

Surveillance imaging in pediatric Hodgkin Lymphoma.

Voss SD.

Curr Hematol Malig Rep. 2013 Sep;8(3):218-25. doi: 10.1007/s11899-013-0168-z. Review.

PMID:
23832681
39.

A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial.

Nehra D, Fallon EM, Potemkin AK, Voss SD, Mitchell PD, Valim C, Belfort MB, Bellinger DC, Duggan C, Gura KM, Puder M.

JPEN J Parenter Enteral Nutr. 2014 Aug;38(6):693-701. doi: 10.1177/0148607113492549. Epub 2013 Jun 14.

40.

Resolving bony abnormality evolves to diffuse large B-cell lymphoma.

Croteau SE, Henderson ER, Billett AL, Gebhardt MC, Voss SD.

Pediatr Blood Cancer. 2013 Oct;60(10):E113-5. doi: 10.1002/pbc.24609. Epub 2013 Jun 4.

PMID:
23737071
41.

A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children.

Ramon-Krauel M, Salsberg SL, Ebbeling CB, Voss SD, Mulkern RV, Apura MM, Cooke EA, Sarao K, Jonas MM, Ludwig DS.

Child Obes. 2013 Jun;9(3):252-60. doi: 10.1089/chi.2013.0022. Epub 2013 May 24.

42.

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

Mossé YP, Lim MS, Voss SD, Wilner K, Ruffner K, Laliberte J, Rolland D, Balis FM, Maris JM, Weigel BJ, Ingle AM, Ahern C, Adamson PC, Blaney SM.

Lancet Oncol. 2013 May;14(6):472-80. doi: 10.1016/S1470-2045(13)70095-0. Epub 2013 Apr 16.

43.

Reliable estimation of incoherent motion parametric maps from diffusion-weighted MRI using fusion bootstrap moves.

Freiman M, Perez-Rossello JM, Callahan MJ, Voss SD, Ecklund K, Mulkern RV, Warfield SK.

Med Image Anal. 2013 Apr;17(3):325-36. doi: 10.1016/j.media.2012.12.001. Epub 2013 Jan 3.

44.

Reliable assessment of perfusivity and diffusivity from diffusion imaging of the body.

Freiman M, Voss SD, Mulkern RV, Perez-Rossello JM, Callahan MJ, Warfield SK.

Med Image Comput Comput Assist Interv. 2012;15(Pt 1):1-9.

45.

In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging.

Freiman M, Voss SD, Mulkern RV, Perez-Rossello JM, Callahan MJ, Warfield SK.

Med Phys. 2012 Aug;39(8):4832-9. doi: 10.1118/1.4736516.

46.

Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group.

Voss SD, Chen L, Constine LS, Chauvenet A, Fitzgerald TJ, Kaste SC, Slovis T, Schwartz CL.

J Clin Oncol. 2012 Jul 20;30(21):2635-40. doi: 10.1200/JCO.2011.40.7841. Epub 2012 Jun 11.

47.

Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.

Malempati S, Weigel B, Ingle AM, Ahern CH, Carroll JM, Roberts CT, Reid JM, Schmechel S, Voss SD, Cho SY, Chen HX, Krailo MD, Adamson PC, Blaney SM.

J Clin Oncol. 2012 Jan 20;30(3):256-62. doi: 10.1200/JCO.2011.37.4355. Epub 2011 Dec 19.

48.

Quantitative body DW-MRI biomarkers uncertainty estimation using unscented wild-bootstrap.

Freiman M, Voss SD, Mulkern RV, Perez-Rossello JM, Warfield SK.

Med Image Comput Comput Assist Interv. 2011;14(Pt 2):74-81.

49.

Leukemia and lymphoma.

Guillerman RP, Voss SD, Parker BR.

Radiol Clin North Am. 2011 Jul;49(4):767-97, vii. doi: 10.1016/j.rcl.2011.05.004. Epub 2011 Jun 25. Review.

PMID:
21807173
50.

A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.

Jakacki RI, Bouffet E, Adamson PC, Pollack IF, Ingle AM, Voss SD, Blaney SM.

Neuro Oncol. 2011 Aug;13(8):910-5. doi: 10.1093/neuonc/nor090. Epub 2011 Jul 15.

Supplemental Content

Support Center